Literature DB >> 4565820

Immunotherapy of cancer. Present status and future potential.

D L Morton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4565820     DOI： 10.1002/1097-0142(197212)30:6<1647::aid-cncr2820300634>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

1.  Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus.

Authors:  A B Miller; H E Taylor; M A Baker; D J Dodds; R Falk; A Frappier; D P Hill; A Jindani; S Landi; A S Macdonald; J W Thomas; C Wall
Journal:  Can Med Assoc J       Date:  1979-07-07       Impact factor: 8.262

Review 2.  Neoplasia--what are the prospects of immunological intervention?

Authors:  B T Rouse
Journal:  Can Vet J       Date:  1973-09       Impact factor: 1.008

3.  The significance of conversion of skin reactivity to efficacy of bacillus Calmette-Guérin (BCG) vaccinations given immediately after radical surgery in stage II melanoma patients.

Authors:  N Cascinelli; P Rümke; R MacKie; A Morabito; R Bufalino
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Cellular immunity, peripheral blood lymphocyte count and pathological staging of tumours in the gastrointestinal tract.

Authors:  G Bone; I Lauder
Journal:  Br J Cancer       Date:  1974-09       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.